New hope for advanced breast cancer: capivasertib combo trial launches
NCT ID NCT07281833
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 22 times
Summary
This phase 3 study tests whether adding capivasertib to standard hormone therapy helps people with HR+/HER2- advanced breast cancer stay on treatment longer and maintain quality of life. About 250 adults whose cancer worsened after prior hormone therapy will take capivasertib plus standard care and report their well-being via questionnaires. The results will be compared to historical data from a similar trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brustzentrum Niederrhein, Johanniter Bethesda Krankenhaus
RECRUITINGMönchengladbach, North Rhine-Westphalia, 41061, Germany
Contact
Contact
Contact
-
CHC MontLegia
NOT_YET_RECRUITINGLiège, 4000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Champalimaud Clinical Centre
NOT_YET_RECRUITINGLisbon, 1400-038, Portugal
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut Jules Bordet
NOT_YET_RECRUITINGAnderlecht, 1070, Belgium
Contact Email: •••••@•••••
Contact
-
St. Elisabeth-Krankenhaus GmbH, Brustzentrum - Senologie
NOT_YET_RECRUITINGCologne, North Rhine-Westphalia, 50935, Germany
Contact
Contact
Contact
Contact
-
Universitätsklinikum Essen
NOT_YET_RECRUITINGEssen, North Rhine-Westphalia, 45130, Germany
Contact
Contact
Contact
Contact
-
Universitätsklinikum Münster AöR Brustzentrum
NOT_YET_RECRUITINGMünster, North Rhine-Westphalia, 48149, Germany
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.